A Study of Effectiveness of Trabectedin for the Treatment of Patients With Specific Subtypes of Metastatic Breast Cancer

This study has been completed.

Study NCT00580112 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: December 20, 2007 Last Updated: December 27, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given